Form 4 for PNR Pentair
Accepted 2025-11-18 00:00:00 ET · period of report 2025-11-14 · accession 0000897069-25-001714 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-11-18 | 2025-11-14 | PNR | Fishman Robert P | EVP, CFO | S - Sale+OE | $105.42 | -7,786 | 63.2K | -11% | -$820.8K |
| DM | 2025-11-18 | 2025-11-14 | PNR | Fishman Robert P | EVP, CFO | M - OptEx | $56.09 | +15.0K | 64.2K | +30% | +$842.1K |
| DM | 2025-11-18 | 2025-11-14 | PNR | Fishman Robert P | EVP, CFO | F - Tax | $105.00 | -3,834 | 63.2K | -6% | -$402.6K |
| DM | 2025-11-18 | 2025-11-14 | PNR | Fishman Robert P | EVP, CFO | M - OptEx | $0.00 | +15.0K | 17.7K | +560% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2025-11-14 | S | D | 321 | $105.52 | 63,164 | D | — | — | (F2) The price in Column 4 is a weighted average price. The prices actually received ranged from $105.00 to $105.598. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. |
| 2 | Common | Common Shares | 2025-11-14 | M | A | 1,431 | $70.99 | 64,595 | D | — | — | |
| 3 | Common | Common Shares | 2025-11-14 | S | D | 1,431 | $105.41 | 63,164 | D | — | — | (F2) The price in Column 4 is a weighted average price. The prices actually received ranged from $105.00 to $105.598. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. |
| 4 | Common | Common Shares | 2025-11-14 | M | A | 1,491 | $45.20 | 64,655 | D | — | — | |
| 5 | Common | Common Shares | 2025-11-14 | S | D | 1,491 | $105.37 | 63,164 | D | — | — | (F2) The price in Column 4 is a weighted average price. The prices actually received ranged from $105.00 to $105.598. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. |
| 6 | Common | Common Shares | 2025-11-14 | M | A | 425 | $70.92 | 63,589 | D | — | — | |
| 7 | Common | Common Shares | 2025-11-14 | S | D | 425 | $105.31 | 63,164 | D | — | — | (F2) The price in Column 4 is a weighted average price. The prices actually received ranged from $105.00 to $105.598. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. |
| 8 | Common | Common Shares | 2025-11-14 | M | A | 476 | $70.92 | 63,640 | D | — | — | |
| 9 | Common | Common Shares | 2025-11-14 | M | A | 321 | $51.53 | 63,485 | D | — | — | |
| 10 | Common | Common Shares | 2025-11-14 | S | D | 1,937 | $105.52 | 63,164 | D | — | — | (F2) The price in Column 4 is a weighted average price. The prices actually received ranged from $105.00 to $105.598. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. |
| 11 | Common | Common Shares | 2025-11-14 | M | A | 1,937 | $51.53 | 65,101 | D | — | — | |
| 12 | Common | Common Shares | 2025-11-14 | S | D | 476 | $105.31 | 63,164 | D | — | — | (F2) The price in Column 4 is a weighted average price. The prices actually received ranged from $105.00 to $105.598. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. |
| 13 | Common | Common Shares | 2025-11-14 | M | A | 1,408 | $70.99 | 64,123 | D | — | — | |
| 14 | Common | Common Shares | 2025-11-14 | F | D | 2,875 | $105.00 | 62,715 | D | — | — | |
| 15 | Common | Common Shares | 2025-11-14 | M | A | 5,820 | $51.53 | 65,590 | D | — | — | |
| 16 | Common | Common Shares | 2025-11-14 | S | D | 619 | $105.41 | 63,164 | D | — | — | (F2) The price in Column 4 is a weighted average price. The prices actually received ranged from $105.00 to $105.598. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. |
| 17 | Common | Common Shares | 2025-11-14 | M | A | 619 | $70.99 | 63,783 | D | — | — | |
| 18 | Common | Common Shares | 2025-11-14 | S | D | 1,086 | $105.37 | 63,164 | D | — | — | (F2) The price in Column 4 is a weighted average price. The prices actually received ranged from $105.00 to $105.598. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. |
| 19 | Common | Common Shares | 2025-11-14 | M | A | 1,086 | $45.20 | 64,250 | D | — | — | |
| 20 | Common | Common Shares | 2025-11-14 | F | D | 959 | $105.00 | 63,164 | D | — | — | |
| 21 | Derivative | Employee Stock Option (right to buy) | 2025-11-14 | M | A | 1,491 | $0.00 | 31,177 | D | $45.20 · — to 2033-01-03 | 1,491 Common Shares | (F5) One-third of the stock options become exercisable on the first, second and third anniversary of the grant. |
| 22 | Derivative | Employee Stock Option (right to buy) | 2025-11-14 | M | A | 425 | $0.00 | 18,172 | D | $70.92 · — to 2034-01-02 | 425 Common Shares | (F5) One-third of the stock options become exercisable on the first, second and third anniversary of the grant. |
| 23 | Derivative | Employee Stock Option (right to buy) | 2025-11-14 | M | A | 1,431 | $0.00 | 19,472 | D | $70.99 · — to 2032-01-03 | 1,431 Common Shares | (F4) This option is presently exercisable in full. |
| 24 | Derivative | Employee Stock Option (right to buy) | 2025-11-14 | M | A | 321 | $0.00 | 26,022 | D | $51.53 · — to 2031-01-04 | 321 Common Shares | (F4) This option is presently exercisable in full. |
| 25 | Derivative | Employee Stock Option (right to buy) | 2025-11-14 | M | A | 1,937 | $0.00 | 26,343 | D | $51.53 · — to 2031-01-04 | 1,937 Common Shares | (F4) This option is presently exercisable in full. |
| 26 | Derivative | Employee Stock Option (right to buy) | 2025-11-14 | M | A | 1,408 | $0.00 | 20,903 | D | $70.99 · — to 2032-01-03 | 1,408 Common Shares | (F4) This option is presently exercisable in full. |
| 27 | Derivative | Employee Stock Option (right to buy) | 2025-11-14 | M | A | 5,820 | $0.00 | 28,280 | D | $51.53 · — to 2031-01-04 | 5,820 Common Shares | (F4) This option is presently exercisable in full. |
| 28 | Derivative | Employee Stock Option (right to buy) | 2025-11-14 | M | A | 619 | $0.00 | 18,853 | D | $70.99 · — to 2032-01-03 | 619 Common Shares | (F5) One-third of the stock options become exercisable on the first, second and third anniversary of the grant. |
| 29 | Derivative | Employee Stock Option (right to buy) | 2025-11-14 | M | A | 1,086 | $0.00 | 30,091 | D | $45.20 · — to 2033-01-03 | 1,086 Common Shares | (F5) One-third of the stock options become exercisable on the first, second and third anniversary of the grant. |
| 30 | Derivative | Employee Stock Option (right to buy) | 2025-11-14 | M | A | 476 | $0.00 | 17,696 | D | $70.92 · — to 2034-01-02 | 476 Common Shares | (F5) One-third of the stock options become exercisable on the first, second and third anniversary of the grant. |